532 related articles for article (PubMed ID: 7800480)
41. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein.
Kim S; Yu SS; Kim VN
J Gen Virol; 1996 Jan; 77 ( Pt 1)():83-91. PubMed ID: 8558131
[TBL] [Abstract][Full Text] [Related]
42. Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.
Toyama R; Bende SM; Dhar R
Nucleic Acids Res; 1992 May; 20(10):2591-6. PubMed ID: 1598218
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans.
Gnabre JN; Brady JN; Clanton DJ; Ito Y; Dittmer J; Bates RB; Huang RC
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11239-43. PubMed ID: 7479972
[TBL] [Abstract][Full Text] [Related]
44. trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences.
Zimmermann K; Dobrovnik M; Ballaun C; Bevec D; Hauber J; Böhnlein E
Virology; 1991 Jun; 182(2):874-8. PubMed ID: 2024503
[TBL] [Abstract][Full Text] [Related]
45. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities.
Michael NL; D'Arcy L; Ehrenberg PK; Redfield RR
J Virol; 1994 May; 68(5):3163-74. PubMed ID: 7908701
[TBL] [Abstract][Full Text] [Related]
46. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression.
Roebuck KA; Gu DS; Kagnoff MF
AIDS; 1996 Jul; 10(8):819-26. PubMed ID: 8828738
[TBL] [Abstract][Full Text] [Related]
47. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
48. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.
Wang L; Mukherjee S; Jia F; Narayan O; Zhao LJ
J Biol Chem; 1995 Oct; 270(43):25564-9. PubMed ID: 7592727
[TBL] [Abstract][Full Text] [Related]
49. COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat in human microglial cells.
Rohr O; Aunis D; Schaeffer E
J Biol Chem; 1997 Dec; 272(49):31149-55. PubMed ID: 9388268
[TBL] [Abstract][Full Text] [Related]
50. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.
El Kharroubi A; Piras G; Zensen R; Martin MA
Mol Cell Biol; 1998 May; 18(5):2535-44. PubMed ID: 9566873
[TBL] [Abstract][Full Text] [Related]
52. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
53. Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.
Macián F; Rao A
Mol Cell Biol; 1999 May; 19(5):3645-53. PubMed ID: 10207088
[TBL] [Abstract][Full Text] [Related]
54. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3.
Krikun G; Schatz F; Mackman N; Guller S; Demopoulos R; Lockwood CJ
Mol Endocrinol; 2000 Mar; 14(3):393-400. PubMed ID: 10707957
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein.
Khalil MI; Ruyechan WT; Hay J; Arvin A
Virology; 2015 Nov; 485():47-57. PubMed ID: 26207799
[TBL] [Abstract][Full Text] [Related]
56. The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.
Lim SP; Garzino-Demo A
J Virol; 2000 Feb; 74(4):1632-40. PubMed ID: 10644332
[TBL] [Abstract][Full Text] [Related]
57. Nitric oxide inhibits HIV tat-induced NF-kappaB activation.
Chen F; Lu Y; Castranova V; Rojanasakul Y; Miyahara K; Shizuta Y; Vallyathan V; Shi X; Demers LM
Am J Pathol; 1999 Jul; 155(1):275-84. PubMed ID: 10393859
[TBL] [Abstract][Full Text] [Related]
58. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation.
Perkins ND; Agranoff AB; Pascal E; Nabel GJ
Mol Cell Biol; 1994 Oct; 14(10):6570-83. PubMed ID: 7935378
[TBL] [Abstract][Full Text] [Related]
59. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
60. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
